Where does Orexigen Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Orexigen Therapeutics, Inc. ranks #32,767 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Orexigen Therapeutics, Inc. hold?

Orexigen Therapeutics, Inc. holds 8 US utility patents granted between 2015 and 2017, spanning 7 technology areas.

What is Orexigen Therapeutics, Inc.'s Innovation Score?

Orexigen Therapeutics, Inc. has an Innovation Score of 25.7 out of 100 (18th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Orexigen Therapeutics, Inc. focus on?

Orexigen Therapeutics, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 8 patents, ranking #2,696 of 7,163 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Orexigen Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Orexigen Therapeutics, Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Orexigen Therapeutics, Inc.'s patents?

Orexigen Therapeutics, Inc.'s patents average 14.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Orexigen Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Orexigen Therapeutics, Inc.

USPTO PatentsView assignee record - 8 granted patents across 7 technology areas, recorded in grant years 2015–2017. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Orexigen ranks #32,767 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 7 technology areas.

#32,767
of 49,997 US assignees by volume: 18th percentile
by Innovation Score (25.7/100): 14.6
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R32767 · US Corporation #32,767 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #32,767/49,997
PHOTO-FINISH Optofluidics
CPC-NARROW A61K · 7 areas
INNOV-THIN 25.7/100
CLAIMS-RICH 14.6 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Optofluidics Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Orexigen’s 25.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (29%) Velocity 0.0 pts (0%) Breadth 9.4 pts (36%) Claim depth 8.8 pts (34%)

Qualcomm Incorporated · highest

85
Orexigen Therapeutics · this assignee

26
3D Lighting… · lowest

7

What this shows Orexigen's Innovation Score is 25.7/100 (18th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Orexigen?

Each dot is one of Orexigen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Orexigen’s own 14.6 claims/patent is at or below the 15.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Orexigen vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Orexigen's grants concentrate

Orexigen Therapeutics, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2015 (4 grants) versus a trough of 2 in 2016. By volume, Orexigen sits between Optofluidics Inc. and Orthodyne Electronics Corporation.

Optofluidics

8
Orbital Composites

8
Orbray

8
Orchid Exchange

8
Orgenesis

8
Orth Consulting

8
Ortho Development

8
Orthodyne

8
Orexigen Therapeu… ◀

8

What this shows Orexigen holds 8 patents at rank #32,761, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Orexigen

By rank, the assignees closest to #32,761 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Orexigen's primary technology class.

Orexigen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 18th percentile higher than 18% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2017

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Orexigen Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	50.0%
2016	2	25.0%
2017	2	25.0%

Which technologies does Orexigen Therapeutics, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 7

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 1

G01G - Weighing 1

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Orexigen Therapeutics, Inc.'s patent record in context - here's where to go next.

Orexigen Therapeutics, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #32,767 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Orexigen Therapeutics, Inc. against Optofluidics Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 25.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.